surmount-1 tirzepatide weight loss results for the Maintenance of Body Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity Clinical trials of subcutaneous tirzepatide
Description
Others prefer the freshness guarantee that comes with a newly mixed vial every 14 days
The FDA-approved minimum age for tirzepatide (Zepbound) is 12 years old

At 10 mg/mL, a standard 1 mL insulin syringe cannot hold your full 15 mg dose

For researchers and individuals using semaglutide for weight management, the full escalation schedule looks like this

Show them to your doctor during your next scheduled visit

The broader issue of protocols not producing expected results is addressed in our guide on tirzepatide not working , which covers multiple potential causes